About
Molbio Diagnostics is a private company based in India, founded in 2000, that specializes in point-of-care molecular diagnostics. The company aims to make precise, rapid, and cost-effective healthcare technologies accessible globally. Its flagship product, the Truenat® real-time PCR platform, is a portable and battery-operated system that provides lab-grade accuracy for diagnosing infectious and non-communicable diseases outside traditional laboratory settings. This system is endorsed by the WHO for tuberculosis and rifampicin resistance detection. The Truenat platform supports the diagnosis of various diseases, including TB, COVID-19, HIV, and breast cancer, among others. It features real-time data transfer capabilities for immediate reporting in critical cases. Molbio operates five manufacturing facilities in India, producing a significant number of test kits and devices annually. The company focuses on decentralizing diagnostics to address healthcare inequities, impacting over 40 million lives in more than 80 countries. Its customer base includes healthcare providers in underserved regions and public health programs, collaborating with global health organizations and research institutions to enhance disease management and monitoring.
Technologies
Keywords
Company Information
-
Employees 700
-
Founded 2000
-
Annual Revenue $120000000
-
Total Funding $117743274
Location
Goa, India, 403722
